Financial Consulate’s Wave Life Sciences WVE Stock Holding History

Financial Consulate’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.19K	Buy	+322	New	+$1.69K	﹤0.01%	1267

Other funds holding WVE

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

James J. Burns & Company Melville, New York $937M AUM 13.35% 1-Year Est. Return

FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.76B AUM 16.09% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Financial Consulate's WVE Position: Q3 2026 in Review

Financial Consulate opened a new position in Wave Life Sciences (WVE) in Q3 2026: 322 shares worth $1.19K. The stake represents ﹤0.01% of the portfolio and ranks #1267 among its holdings.

16 funds tracked by Wall St. Rank hold WVE as of Q3 2026.

Financial Consulate held 322 shares of Wave Life Sciences worth $1.19K as of Q3 2026.
Wave Life Sciences was a new Financial Consulate position in Q3 2026.
Wave Life Sciences made up ﹤0.01% of Financial Consulate's portfolio in Q3 2026, its #1267 holding.
16 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2026.

Based on Financial Consulate's 13F filing for Q3 2026, filed 23 Oct 2026.